Suppr超能文献

钯(II)和铂(II)与4,7-二氢-5-甲基-7-氧代[1,2,4]三唑并[1,5-a]嘧啶形成的有机金属配合物。铂化合物的抗肿瘤活性。

Palladium(II) and platinum(II) organometallic complexes with 4,7-dihydro-5-methyl-7-oxo[1,2,4]triazolo[1,5-a]pyrimidine. Antitumor activity of the platinum compounds.

作者信息

Ruiz José, Villa María Dolores, Cutillas Natalia, López Gregorio, de Haro Concepción, Bautista Delia, Moreno Virtudes, Valencia Laura

机构信息

Departamento de Química Inorgánica, Universidad de Murcia, E-30071-Murcia, Spain.

出版信息

Inorg Chem. 2008 Jun 2;47(11):4490-505. doi: 10.1021/ic701873b. Epub 2008 Apr 30.

Abstract

Palladium and platinum complexes with HmtpO (where HmtpO=4,7-dihydro-5-methyl-7-oxo[1,2,4]triazolo[1,5-a]pyrimidine, an analogue of the natural occurring nucleobase hypoxanthine) of the types [M(dmba)(PPh3)(HmtpO)]ClO4[dmba=N,C-chelating 2-(dimethylaminomethyl)phenyl; M=Pd or Pt], [Pd(N-N)(C6F5)(HmtpO)]ClO4[N-N=2,2'-bipyridine (bpy), 4,4'-dimethyl-2,2'-bipyridine (Me2bpy), or N, N, N', N'-tetramethylethylenediamine (tmeda)] and cis-[M(C6F5)2(HmtpO)2] (M=Pd or Pt) (head-to-head atropisomer in the solid state) have been obtained. Pd(II) and Pt(II) complexes with the anion of HmtpO of the types [Pd(tmeda)(C6F5)(mtpO)], [Pd(dmba)(micro-mtpO)] 2, and [NBu4]2[M(C6F5)2(micro-mtpO)]2(M=Pd or Pt) have been prepared starting from the corresponding hydroxometal complexes. Complexes containing simultaneously both the neutral HmtpO ligand and the anionic mtpO of the type [NBu4][M(C6F5)2(HmtpO)(mtpO)] (M=Pd or Pt) have been also obtained. In these mtpO-HmtpO metal complexes, for the first time, prototropic exchange is observed between the two heterocyclic ligands. The crystal structures of [Pd(dmba)(PPh 3)(HmtpO)]+, cis-[Pt(C6F5)2(HmtpO)2].acetone, [Pd(C6F5)(tmeda)(mtpO)].2H2O, [Pd(dmba)(micro-mtpO)]2, [NBu4]2[Pd(C6F5)2(micro-mtpO)]2.CH2Cl2.toluene, [NBu4]2Pt(C6F5)2(micro-mtpO).0.5(toluene), and [NBu4][Pt(C6F5)2(mtpO)(HmtpO)] have been established by X-ray diffraction. Values of IC50 were calculated for the new platinum complexes cis-[Pt(C6F5)2(HmtpO)2] and [Pt(dmba)(PPh3)(HmtpO)]ClO4 against a panel of human tumor cell lines representative of ovarian (A2780 and A2780 cisR), lung (NCI-H460), and breast cancers (T47D). At 48 h incubation time, both complexes were about 8-fold more active than cisplatin in T47D and show very low resistance factors against an A2780 cell line, which has acquired resistance to cisplatin. The DNA adduct formation of cis-[Pt(C6F5)2(HmtpO)2] and [Pt(dmba)(PPh3)(HmtpO)]ClO4 was followed by circular dichroism and electrophoretic mobility. Atomic force microscopy images of the modifications caused by these platinum complexes on plasmid DNA pB R322 were also obtained.

摘要

已制得钯和铂与HmtpO(其中HmtpO = 4,7 - 二氢 - 5 - 甲基 - 7 - 氧代[1,2,4]三唑并[1,5 - a]嘧啶,天然存在的核碱基次黄嘌呤的类似物)形成的配合物,其类型为[M(dmba)(PPh₃)(HmtpO)]ClO₄[dmba = N,C - 螯合的2 - (二甲基氨基甲基)苯基;M = Pd或Pt]、[Pd(N - N)(C₆F₅)(HmtpO)]ClO₄[N - N = 2,2'- 联吡啶(bpy)、4,4'- 二甲基 - 2,2'- 联吡啶(Me₂bpy)或N,N,N',N'- 四甲基乙二胺(tmeda)]以及顺式 - [M(C₆F₅)₂(HmtpO)₂](M = Pd或Pt)(固态下为头对头阻转异构体)。已从相应的羟基金属配合物出发,制备了类型为[Pd(tmeda)(C₆F₅)(mtpO)]、[Pd(dmba)(μ - mtpO)]₂和[NBu₄]₂[M(C₆F₅)₂(μ - mtpO)]₂(M = Pd或Pt)的钯(II)和铂(II)与HmtpO阴离子形成的配合物。还获得了同时含有中性HmtpO配体和阴离子mtpO的类型为[NBu₄][M(C₆F₅)₂(HmtpO)(mtpO)](M = Pd或Pt)的配合物。在这些mtpO - HmtpO金属配合物中,首次观察到两个杂环配体之间的质子转移交换。通过X射线衍射确定了[Pd(dmba)(PPh₃)(HmtpO)]⁺、顺式 - [Pt(C₆F₅)₂(HmtpO)₂]·丙酮、[Pd(C₆F₅)(tmeda)(mtpO)]·2H₂O、[Pd(dmba)(μ - mtpO)]₂、[NBu₄]₂[Pd(C₆F₅)₂(μ - mtpO)]₂·CH₂Cl₂·甲苯、[NBu₄]₂[Pt(C₆F₅)₂(μ - mtpO)]₂·0.5(甲苯)和[NBu₄][Pt(C₆F₅)₂(mtpO)(HmtpO)]的晶体结构。针对一组代表卵巢癌(A2780和A2780 cisR)、肺癌(NCI - H460)和乳腺癌(T₄₇D)的人类肿瘤细胞系,计算了新型铂配合物顺式 - [Pt(C₆F₅)₂(HmtpO)₂]和[Pt(dmba)(PPh₃)(HmtpO)]ClO₄的IC₅₀值。在48小时的孵育时间下,两种配合物在T₄₇D细胞系中的活性均比顺铂高约8倍,并且对已获得顺铂抗性的A2780细胞系显示出非常低的耐药因子。通过圆二色性和电泳迁移率跟踪了顺式 - [Pt(C₆F₅)₂(HmtpO)₂]和[Pt(dmba)(PPh₃)(HmtpO)]ClO₄的DNA加合物形成。还获得了这些铂配合物对质粒DNA pBR322造成修饰的原子力显微镜图像。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验